Need professional-grade analysis? Visit stockanalysis.com
$216.17M
N/A
N/A
N/A
Nuvectis Pharma Inc (NVCT) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $8.58, down 3.60% from the previous close.
Over the past year, NVCT has traded between a low of $5.65 and a high of $10.96. The stock has lost 17.6% over this period. It is currently 21.7% below its 52-week high.
Nuvectis Pharma Inc has a market capitalization of $216.17M.
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Side-by-side comparison against top Healthcare peers.